Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 24, 2004, Pages 6001-6006

  Zimmerman, Sabrina ^a   Innocenti, Alessio ^b   Casini, Angela ^b   Ferry, James G ^a   Scozzafava, Andrea ^b   Supuran, Claudiu T ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BACTERIAL ENZYME; CARBONATE DEHYDRATASE INHIBITOR; CELECOXIB; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; HEPSULFAM; ISOENZYME; MAFENIDE; METHAZOLAMIDE; SULFANILAMIDE; SULFANILAMIDE DERIVATIVE; SULFONAMIDE; TOPIRAMATE; VALDECOXIB;

ARCHAEBACTERIUM; ARTICLE; BINDING AFFINITY; DRUG POTENCY; ENZYME INHIBITION; METHANOBACTERIUM THERMOAUTOTROPHICUM; METHANOSARCINA; PROKARYOTE; STRUCTURE ACTIVITY RELATION;

ARCHAEA; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; HUMANS; ISOENZYMES; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

ARCHAEA; METHANOBACTERIUM; METHANOSARCINA; METHANOSARCINA THERMOPHILA; METHANOTHERMOBACTER THERMAUTOTROPHICUS;

EID: 8844286179     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.09.085     Document Type: Article

References (47)

1. G. Domagk Dtsch. Med. Wochenschr. 61 1935 250 253
2. G.L. Mandell, and W.A. Petri Antimicrobial Agents. Sulfonamides, Trimethoprim-sulfamethoxazole, and Agents for Urinary Tract Infections J.G. Hardman L.E. Limbird P.B. Molinoff R.W. Ruddon A.G. Gilman Goodman's and Gilman's the Pharmacological Basis of Therapeutics 9th ed. 1996 McGraw-Hill New York 1057 1072
3. C.T. Supuran A. Scozzafava J. Conway Carbonic Anhydrase-Its Inhibitors and Activators 2004 CRC Boca Raton (FL), USA pp 1-363
4. A. Scozzafava, A. Mastrolorenzo, and C.T. Supuran Expert Opin. Ther. Pat. 14 2004 67 702
5. C.T. Supuran, A. Scozzafava, and A. Casini Med. Res. Rev. 23 2003 146 189
6. C.T. Supuran Carbonic Anhydrases: Catalytic Mechanism, Distribution and Physiological Roles C.T. Supuran A. Scozzafava J. Conway Carbonic Anhydrase-Its Inhibitors and Activators 2004 CRC Boca Raton (FL), USA 1 24
7. C.T. Supuran, and A. Scozzafava Expert Opin. Ther. Pat. 10 2000 575 600
8. C.T. Supuran, A. Scozzafava, and B.W. Clare Med. Res. Rev. 22 2002 329 372
9. C.T. Supuran, and A. Scozzafava Matrix Metalloproteinases (MMPs) H.J. Smith C. Simons Proteinase and Peptidase Inhibition: Recent Potential Targets for Drug Development 2002 Taylor & Francis Publishing House London and New York 35 61
10. X. de Leval, F. Julémont, J. Delarge, V. Sanna, B. Pirotte, and J.-M. Dogné Expert Opin. Ther. Pat. 12 2002 969 989
11. A. Weber, A. Casini, A. Heine, D. Kuhn, C.T. Supuran, A. Scozzafava, and G. Klebe J. Med. Chem. 47 2004 550 557
12. C.T. Supuran, A. Casini, A. Mastrolorenzo, and A. Scozzafava Mini-Rev. Med. Chem. 4 2004 625 632
13. R.D. Tung, D.J. Livingston, B.G. Rao, E.E. Kim, C.T. Baker, J.S. Boger, S.P. Chambers, D.D. Deininger, M. Dwyer, L. Elsayed, J. Fulghum, M. Li, M.A. Murcko, M.A. Navia, P. Novak, S. Pazhanisamy, C. Stuver, and J.A. Thomson Design and Synthesis of Amprenavir, a Novel HIV Protease Inhibitor R.C. Ogden C.W. Flexner Protease Inhibitors in AIDS Therapy 2001 Marcel Dekker New York 101 118
14. A. Scozzafava, T. Owa, A. Mastrolorenzo, and C.T. Supuran Curr. Med. Chem. 10 2003 925 953
15. T. Owa, and T. Nagasu Expert Opin. Ther. Pat. 10 2000 1725 1740
16. C.T. Supuran Expert Opin. Invest. Drugs 12 2003 283 287
17. F. Abbate, A. Casini, T. Owa, A. Scozzafava, and C.T. Supuran Bioorg. Med. Chem. Lett. 14 2004 217 223
18. A.E. Boyd Diabetes 37 1988 847 850
19. C.T. Supuran, A. Casini, and A. Scozzafava Development of Sulfonamide Carbonic Anhydrase Inhibitors (CAIs) C.T. Supuran A. Scozzafava J. Conway Carbonic Anhydrase-Its Inhibitors and Activators 2004 CRC Boca Raton, FL, USA 67 148
20. B.C. Tripp, K.S. Smith, and J.G. Ferry J. Biol. Chem. 276 2001 48615 48618
21. K.S. Smith, and J.G. Ferry FEMS Microbiol. Rev. 24 2000 335 366
22. K.S. Smith, C. Jakubzick, T.S. Whittam, and J.G. Ferry Proc. Natl. Acad. Sci. U.S.A. 96 1999 15185 15189
23. T.M. Iverson, B.E. Alber, C. Kisker, J.G. Ferry, and D.C. Rees Biochemistry 39 2000 9222 9231
24. E.H. Cox, G.L. McLendon, F.M. Morel, T.W. Lane, R.C. Prince, I.J. Pickering, and G.N. George Biochemistry 39 2000 12128 12130
25. T.W. Lane, and F.M. Morel Proc. Natl. Acad. Sci. U.S.A. 97 2000 4627 4631
26. A.K. So, G.S. Espie, E.B. Williams, J.M. Shively, S. Heinhorst, and G.C. Cannon J. Bacteriol. 186 2004 623 630
27. K.S. Smith, and J.G. Ferry J. Bacteriol. 181 1999 6247 6253
28. K.S. Smith, N.J. Cosper, C. Stalhandske, R.A. Scott, and J.G. Ferry J. Bacteriol. 182 2000 6605 6613
29. K.S. Smith, C. Ingram-Smith, and J.G. Ferry J. Bacteriol. 184 2002 4240 4245
30. A. Innocenti, S. Zimmerman, J.G. Ferry, A. Scozzafava, and C.T. Supuran Bioorg. Med. Chem. Lett. 14 2004 3327 3331
31. A. Innocenti, S. Zimmerman, J.G. Ferry, A. Scozzafava, and C.T. Supuran Bioorg. Med. Chem. Lett. 14 2004 4563 4567
32. A. Scozzafava, L. Menabuoni, F. Mincione, F. Briganti, G. Mincione, and C.T. Supuran J. Med. Chem. 42 1999 2641 2650
33. B.W. Clare, and C.T. Supuran Eur. J. Med. Chem. 34 1999 463 474
34. Human CA I, and CA II cDNAs were expressed in Escherichia coli strain BL21 (DE3) from the corresponding plasmids described by Lindskog's group (S. Lindskog, G. Behravan, C. Engstrand, C. Forsman, B.H. Jonsson, Z. Liang, X. Ren, and Y. Xue F. Botrè G. Gros B.T. Storey Carbonic Anhydrase-From Biochemistry and Genetics to Physiology and Clinical Medicine 1991 VCH Weinheim 1 13)
35. 26
36. G. Behravan, B.H. Jonsson, and S. Lindskog Eur. J. Biochem. 190 1990 351 357
37. S. Lindskog, and J.E. Coleman Proc. Natl. Acad. Sci. U.S.A. 70 1964 2505 2508
38. H. Steiner, B.H. Jonsson, and S. Lindskog Eur. J. Biochem. 59 1975 253 259
39. J.R. Casey, P.E. Morgan, D. Vullo, A. Scozzafava, A. Mastrolorenzo, and C.T. Supuran J. Med. Chem. 47 2004 2337 2347
40. 2 solutions in water at 20°C were used as substrate. Stock solutions of inhibitors were prepared at a concentration of 10-200 mM (in the assay buffer) and dilutions up to 0.01 μM done with the assay buffer mentioned above. Enzyme concentrations were 0.09 μM for hCA I and hCA IX, 0.1 μM for Cab, and 0.01 μM for hCA II, Zn-Cam and Co-Cam. Inhibition constants were calculated as described by Khalifah, R. G. J. Biol. Chem. 1971, 246, 2561-2573, and are the mean form three different determinations
41. D. Vullo, M. Franchi, E. Gallori, J. Pastorek, A. Scozzafava, S. Pastorekova, and C.T. Supuran Bioorg. Med. Chem. Lett. 13 2003 1005 1009
42. F. Briganti, R. Pierattelli, A. Scozzafava, and C.T. Supuran Eur. J. Med. Chem. 31 1996 1001 1010
43. C. Forsman Plant Carbonic Anhydrases: Structure and Mechanism W.R. Chegwidden N. Carter Y. Edwards The Carbonic Anhydrases-New Horizons 2000 Birkhauser Basel, Switzerland 519 534
44. A. Casini, J. Antel, F. Abbate, A. Scozzafava, S. David, H. Waldeck, S. Schäfer, and C.T. Supuran Bioorg. Med. Chem. Lett. 13 2003 841 845
45. M.A. Ilies, D. Vullo, J. Pastorek, A. Scozzafava, M. Ilies, M.T. Caproiu, S. Pastorekova, and C.T. Supuran J. Med. Chem. 46 2003 2187 2196
46. B.C. Tripp, C.B. Bell III, F. Cruz, C. Krebs, and J.G. Ferry J. Biol. Chem. 279 2004 6683 6687
47. F. Abbate, C.T. Supuran, A. Scozzafava, P. Orioli, M.T. Stubbs, and G. Klebe J. Med. Chem. 45 2002 3583 3587